Literature DB >> 18227546

Obscure gastrointestinal bleeding: evaluation with 64-section multiphase CT enterography--initial experience.

James E Huprich1, Joel G Fletcher, Jeffrey A Alexander, Jeff L Fidler, Sharon S Burton, Cynthia H McCullough.   

Abstract

This retrospective HIPAA-compliant study was approved by the institutional review board and institutional conflict of interest committee. Patients gave informed consent for use of medical records. The purpose of the study was to retrospectively evaluate the findings depicted at computed tomographic (CT) enterography performed with a 64-section CT system and by using neutral enteric contrast material and a three-phase acquisition in patients with obscure gastrointestinal bleeding (OGIB). Twenty-two outpatients (11 men, 11 women; age range, 37-83 years) with OGIB underwent CT enterography. Findings were compared with capsule and traditional endoscopic, surgical, and angiographic findings. CT enterographic findings were positive for a bleeding source in 10 (45%) of 22 patients. Eight of 10 positive findings at CT enterography were also positive at capsule endoscopy or subsequent clinical diagnosis. CT enterography helped correctly identify three lesions undetected at capsule endoscopy. Study results suggest that multiphase, multiplanar CT enterography may have a role in the evaluation of OGIB. (c) RSNA, 2008.

Entities:  

Mesh:

Year:  2008        PMID: 18227546     DOI: 10.1148/radiol.2462061920

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

1.  Clinical impact of multidetector computed tomography before double-balloon enteroscopy for obscure gastrointestinal bleeding.

Authors:  Hsu-Heng Yen; Yang-Yuan Chen; Chia-Wei Yang; Chi-Kuang Liu; Maw-Soan Soon
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

2.  MDCT appearance of the appendix: how does the low-density barium sulfate oral contrast agent affect it?

Authors:  Vahid Yaghmai; Anahita Aghaei-Lasboo; Warren M Brandwein; Sandra Tochetto; John N Mafi; Frank H Miller; Paul Nikolaidis
Journal:  Emerg Radiol       Date:  2010-08-04

3.  The role of capsule endoscopy after negative CT enterography in patients with obscure gastrointestinal bleeding.

Authors:  Hyun Mi Heo; Chan Hyuk Park; Joon Seok Lim; Jin Ha Lee; Bo Kyung Kim; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Sung Pil Hong
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

4.  Therapeutic management options for patients with obscure gastrointestinal bleeding.

Authors:  Gursimran S Kochhar; Madhusudhan R Sanaka; John J Vargo
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

5.  Evaluation of dual-phase multi-detector-row CT for detection of intestinal bleeding using an experimental bowel model.

Authors:  Martin Dobritz; Heinz-Peter Engels; Armin Schneider; Hinrich Wieder; Hubertus Feussner; Ernst J Rummeny; Jens C Stollfuss
Journal:  Eur Radiol       Date:  2008-11-19       Impact factor: 5.315

Review 6.  Newer CT applications and their alternatives: what is appropriate in children?

Authors:  R Paul Guillerman
Journal:  Pediatr Radiol       Date:  2011-08-17

7.  CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester.

Authors:  Fayaz A Hakim; Jeffrey A Alexander; James E Huprich; Madhusudan Grover; Felicity T Enders
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.199

Review 8.  Occult and obscure gastrointestinal bleeding: causes and clinical management.

Authors:  Don C Rockey
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-30       Impact factor: 46.802

Review 9.  Current treatment of lower gastrointestinal hemorrhage.

Authors:  Tal Raphaeli; Raman Menon
Journal:  Clin Colon Rectal Surg       Date:  2012-12

10.  Meckel's diverticulum bleeding diagnosed with magnetic resonance enterography: a case report.

Authors:  Fu-Run Zhou; Liu-Ye Huang; Hai-Zhu Xie
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.